Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 31, 2024 07:45 ET | Source: Neurimmune AG

Neurimmune to regain global rights to brain amyloid depleter for the treatment of Alzheimer’s disease

ZURICH, Switzerland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Neurimmune announced today that it regained global rights to aducanumab, a recombinant human antibody developed to deplete brain amyloid....